Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: Prescription According to Reimbursement Constraints and Guideline Recommendations in Catalonia

by Josep Franch-Nadal, Manel Mata-Cases, Emilio Ortega, Jordi Real, Mònica Gratacòs, Bogdan Vlacho, Joan Antoni Vallés, Dídac Mauricio
Published 2019-09-01

Cardiovascular and mortality benefits of sodium–glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia

by Jordi Real, Bogdan Vlacho, Emilio Ortega, Joan Antoni Vallés, Manel Mata-Cases, Esmeralda Castelblanco, Eric T. Wittbrodt, Peter Fenici, Mikhail Kosiborod, Dídac Mauricio, Josep Franch-Nadal
Published 2021-07-01

Analysis of the Adherence and Safety of Second Oral Glucose-Lowering Therapy in Routine Practice From the Mediterranean Area: A Retrospective Cohort Study

by Bogdan Vlacho, Bogdan Vlacho, Bogdan Vlacho, Manel Mata-Cases, Manel Mata-Cases, Xavier Mundet-Tudurí, Xavier Mundet-Tudurí, Joan-Antoni Vallès-Callol, Jordi Real, Jordi Real, Magi Farre, Magi Farre, Xavier Cos, Xavier Cos, Kamlesh Khunti, Dídac Mauricio, Dídac Mauricio, Dídac Mauricio, Dídac Mauricio, Josep Franch-Nadal, Josep Franch-Nadal
Published 2021-07-01